Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Lymphoma, B-Cell × Immunotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 37 Lung Neoplasms 14 Melanoma 13 Neoplasm Metastasis 12 Esophageal Neoplasms 10 Carcinoma, Hepatocellular 10 Breast Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 6 Esophageal Squamous Cell Carcinoma 6 Rectal Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Brain Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Recurrence 3 Neoplasms 3 Multiple Myeloma 3 Cholangiocarcinoma 3 Carcinoma, Renal Cell 3 Small Cell Lung Carcinoma 2 Sarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pathologic Complete Response 2 Pancreatic Neoplasms 2 Neuroblastoma 2 Neoplasm, Residual 2 Nasopharyngeal Carcinoma 2 Locally Advanced Non-small Cell Lung Cancer 2

Interventions

Cyclophosphamide 59 Rituximab 52 fludarabine 38 Etoposide 19 Lenalidomide 18 fludarabine phosphate 16 Doxorubicin 14 Vincristine 12 Magnetic Resonance Spectroscopy 12 Immunotherapy, Adoptive 12 Cytarabine 12 Prednisone 11 pembrolizumab 10 Specimen Handling 9 CT-P10 9 Biopsy 8 obinutuzumab 7 ibrutinib 7 Radiotherapy 7 Carboplatin 7 Bortezomib 7 Bendamustine Hydrochloride 7 Mycophenolic Acid 6 Leukapheresis 6 Ifosfamide 6 zanubrutinib 5 Nivolumab 5 Melphalan 5 Injections 5 Gemcitabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00558220 2007-11-14

R-MCEB

Czech Lymphoma Study Group

Phase 2 Completed

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡